From: Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study
Measure | Group | N | Mean | Minimum | Maximum | SD |
---|---|---|---|---|---|---|
Age | FXS | 18 | 20.54 | 15.39 | 25.85 | 3.57 |
Comparison | 18 | 19.80 | 16.59 | 25.85 | 2.61 | |
Verbal IQ | FXS | 18 | 80.22 | 46 | 119 | 21.08 |
Comparison | 18 | 72.56 | 46 | 100 | 18.77 | |
Performance IQ | FXS | 18 | 72.78 | 48 | 118 | 18.46 |
Comparison | 18 | 76.89 | 55 | 121 | 20.36 | |
Full Scale IQ | FXS | 18 | 74.56 | 44 | 119 | 20.61 |
Comparison | 18 | 72.72 | 48 | 111 | 19.68 | |
Contingency Naming Test (CNT) | FXS | 16 | 17.73 | 6.61 | 47.65 | 10.32 |
Comparison | 16 | 17.02 | 4.29 | 36.00 | 9.93 | |
Aberrant Behavior Checklist | FXS | 15 | 19.33 | 0 | 90 | 24.85 |
Comparison | 17 | 19.65 | 0 | 74 | 19.68 | |
Achenbach attention | FXS | 17 | 59.65 | 50 | 83 | 9.36 |
Comparison | 17 | 62.35 | 50 | 75 | 6.70 | |
Medications | Â | N | Percent (%) | Â | Â | Â |
SSRI | FXS | 4 | 22.22 | Â | Â | Â |
Comparison | 3 | 16.67 | Â | Â | Â | |
Stimulants | FXS | 2 | 11.11 | Â | Â | Â |
Comparison | 7 | 38.88 | Â | Â | Â | |
Other | FXS | 4 | 22.22 | Â | Â | Â |
Comparison | 0 | 0 | Â | Â | Â | |
Medication-free | FXS | 10 | 27.78 | Â | Â | Â |
Comparison | 10 | 27.78 | Â | Â | Â |